Literature DB >> 23471481

Fusobacterium invasive infections in children: a retrospective study in two French tertiary care centres.

M Bailhache1, P Mariani-Kurkdjian, P Lehours, J Sarlangue, P Pillet, E Bingen, A Faye.   

Abstract

The purpose of this investigation was to describe the clinical and biological characteristics and evolution of invasive Fusobacterium infections in children admitted to two French paediatric tertiary care centres. Children who were admitted from 1998 to 2009 to two tertiary care centres for invasive Fusobacterium infection were included in a retrospective study. Thirty-one children with a median age of 5.7 years (interquartile range, IQR [2.3; 9.3]) were included. Nine children had an underlying condition, most commonly sickle cell disease (n = 3) or immunodeficiency (n = 3). Two children had skin effraction prior to the infection. The major sites of infection were the head and neck (n = 14) and abdomen (n = 10). Three children suffered from atypical Lemierre's syndrome. More than half of the children had a bacterial co-infection (58 %). Six children were hospitalised in an intensive care unit, and 67 % of them had a chronic underlying disease. None of the children died. Six children with negative cultures had Fusobacterium identified through 16S RNA-PCR. Fusobacterium is responsible for severe infection in children. Microbiological diagnosis might be improved by the wider use of molecular detection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23471481     DOI: 10.1007/s10096-013-1848-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

1.  [Case of subdural empyema caused by Porphyromonas and Fusobacterium identified by 16S ribosomal RNA gene sequence analysis].

Authors:  Saiko Aiba; Yuka Watanabe; Masaaki Odaka; Toshiki Nakamura; Koichi Hirata
Journal:  Rinsho Shinkeigaku       Date:  2010-05

Review 2.  Fusobacterial infections: clinical spectrum and incidence of invasive disease.

Authors:  Paul J Huggan; David R Murdoch
Journal:  J Infect       Date:  2008-09-20       Impact factor: 6.072

3.  Fusobacterium osteomyelitis in a child with sickle cell disease.

Authors:  Sandra J Murray; Jay M Lieberman
Journal:  Pediatr Infect Dis J       Date:  2002-10       Impact factor: 2.129

4.  Detection of Fusobacterium necrophorum subsp. funduliforme in tonsillitis in young adults by real-time PCR.

Authors:  A Jensen; L Hagelskjaer Kristensen; J Prag
Journal:  Clin Microbiol Infect       Date:  2007-04-02       Impact factor: 8.067

5.  Characteristics and outcomes of Fusobacterium nucleatum bacteremia--a 6-year experience at a tertiary care hospital in northern Taiwan.

Authors:  Chien-Chang Yang; Jung-Jr Ye; Po-Chang Hsu; Hong-Jyun Chang; Chun-Wen Cheng; Hsieh-Shong Leu; Ping-Cherng Chiang; Ming-Hsun Lee
Journal:  Diagn Microbiol Infect Dis       Date:  2011-06       Impact factor: 2.803

6.  Fusobacterium nucleatum bacteraemia with multiple liver abscesses in an HIV-I antibody positive man with IgG2 deficiency.

Authors:  A Scoular; G D Corcoran; A Malin; B A Evans; A Davies; R F Miller
Journal:  J Infect       Date:  1992-05       Impact factor: 6.072

Review 7.  Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a Children's Hospital.

Authors:  Susan Ramirez; Tannaz G Hild; Colin N Rudolph; John R Sty; Susan C Kehl; Peter Havens; Kelly Henrickson; Michael J Chusid
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

8.  Anaerobic bacteremia: decreasing rate over a 15-year period.

Authors:  C W Dorsher; J E Rosenblatt; W R Wilson; D M Ilstrup
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

9.  Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases.

Authors:  P Fanourgiakis; M Vekemans; A Georgala; D Daneau; A Vandermies; P Grenier; M Aoun
Journal:  Support Care Cancer       Date:  2003-03-13       Impact factor: 3.603

10.  Lemierre's syndrome and genetic polymorphisms: a case report.

Authors:  Jean-Michel Constantin; Jean-Paul Mira; Renaud Guerin; Sophie Cayot-Constantin; Olivier Lesens; Florence Gourdon; Jean-Pierre Romaszko; Philippe Linval; Henri Laurichesse; Jean-Etienne Bazin
Journal:  BMC Infect Dis       Date:  2006-07-17       Impact factor: 3.090

View more
  6 in total

1. 

Authors:  Karen Arane; Ran D Goldman
Journal:  Can Fam Physician       Date:  2016-10       Impact factor: 3.275

2.  Fusobacterium infections in children.

Authors:  Karen Arane; Ran D Goldman
Journal:  Can Fam Physician       Date:  2016-10       Impact factor: 3.275

3.  Infections caused by Fusobacterium in children: a 14-year single-center experience.

Authors:  Oded Shamriz; Dan Engelhard; Violeta Temper; Shoshana Revel-Vilk; Shmuel Benenson; Rebecca Brooks; Ariel Tenenbaum; Polina Stepensky; Benjamin Koplewitz; Michal Kaufmann; Diana Averbuch
Journal:  Infection       Date:  2015-05-01       Impact factor: 3.553

Review 4.  Fusobacterium necrophorum otitis and mastoiditis in infants and young toddlers.

Authors:  T Stergiopoulou; T J Walsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-07       Impact factor: 3.267

5.  Acute sore throat and Fusobacterium necrophorum in primary healthcare: a systematic review and meta-analysis.

Authors:  Stefan Malmberg; Susanna Petrén; Ronny Gunnarsson; Katarina Hedin; Pär-Daniel Sundvall
Journal:  BMJ Open       Date:  2021-06-04       Impact factor: 2.692

6.  Oral Pathogen Fusobacterium nucleatum Coaggregates With Pseudomonas aeruginosa to Modulate the Inflammatory Cytotoxicity of Pulmonary Epithelial Cells.

Authors:  Qian Li; Hongyan Wang; Lisi Tan; Shuwei Zhang; Li Lin; Xiaolin Tang; Yaping Pan
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.